Skip to main content
Fig. 3 | BMC Bioinformatics

Fig. 3

From: Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer

Fig. 3

Development and validation of the tumor-infiltrating lymphocyte-related gene signature (TILRGS). a, b LASSO regression analysis; c Multivariate Cox model of five TILRGs; dg The Kaplan–Meier curves in the TCGA-training cohort, TCGA-testing cohort, TCGA-all cohort and GEO-testing cohort, respective; hk ROC analysis for OS prediction including 1, 3, and 5 years of BCa patients in the TCGA-training cohort, TCGA-testing cohort, TCGA-all cohort and GEO-testing cohort, respective; lo Distribution of risk score, scatter plot of the overall survival of each patient, heat map of huh TILRGs expression level in the TCGA-training cohort, TCGA-testing cohort, TCGA-all cohort and GEO-testing cohort, respective. *P < 0.05; **P < 0.01

Back to article page